Polychemotherapy without prednisone in Hodgkin's disease
Longueville, J.; Syenave, P.; Beauduin, M.; Maisin, H.
Acta Clinica Belgica 30(4): 283-289
1975
ISSN/ISBN: 1784-3286 PMID: 1211049 Document Number: 85466
Document emailed within 1 workday
Related Documents
Makhonova, L.A.; Poliakov, V.E.; Susuleva, N.A.; Il'iashenko, V.V. 1981: Role of polychemotherapy in the program treatment of children with Hodgkin's disease Pediatriia 1981(8): 36-39Ignashina, E.V.; Rasstrigin, N.A.; Margolin, O.V.; Pivnik, A.V.; Shilin, D.E. 1999: Protection of reproduction function in women with Hodgkin's disease in the course of polychemotherapy Terapevticheskii Arkhiv 71(10): 29-32
Diehl, L.F.; Perry, D.J.; Terebelo, H.; Baldwin, P.E.; Hurwitz, M.; Kimball, D.B.; Dorn, R.V. 1983: Radiation as salvage therapy for patients with Hodgkin's disease relapsing after MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy Cancer Treatment Reports 67(9): 827-829
Miller, T.P.; Jones, S.E.; Rainey, J.M. 1983: Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in patients with advanced Hodgkin's disease: a Southwest Oncology Group Phase Ii Study Cancer Treatment Reports 67(7-8): 739-740
Stolzenbach, G.; Garbrecht, M.; Müllerleile, U. 1978: Intermittent chlorambucil-prednisone therapy in low malignancy non-Hodgkin lymphoma and cyclic induction chemotherapy with COP-bleomycin of severe non-Hodgkin lymphoma according to the Kiel classification Verhandlungen der Deutschen Gesellschaft für Innere Medizin 84: 177-180
Komarnicki, M.; Balcerzak, A.; Górski, P.; Pawlak, L.; Hansz, J. 1994: Treatment outcome of advanced Hodgkin's disease based on using an alternating program ChLVPP (chlorambucil, vinblastine, procarbazine, prednisone) and ABV (doxorubicin, bleomycin, vinblastine) Acta Haematologica Polonica 25(4): 363-368
Gobbi, P.G.; Pieresca, C.; Cavanna, L.; Corbella, F.; Vallisa, D.; Federico, M.; Formisano, R.; Carotenuto, M.; Merli, F.; Callea, V.; Angrilli, F.; Silingardi, V. 1996: CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease. a prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL) Haematologica 81(6): 503-512
Belić, A.; Popović, S.; Savić, I. 1992: Effect of polychemotherapy in the treatment of patients with non-Hodgkin's lymphoma Medicinski Pregled 45(5-6): 188-193
Hansen, M.M.; Bloomfield, C.D.; Jørgensen, J.; Ersbøll, J.; Pedersen-Bjergaard, J.; Blom, J.; Nissen, N.I. 1980: VP-16-213 in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone in the treatment of non-Hodgkin's lymphomas Cancer Treatment Reports 64(10-11): 1135-1137
Alekseeva, I.A.; Zaritskiĭ, A.I.; Medvedeva, N.V.; Mikhaĭlova, N.B.; Zubarovskaia, L.S.; Afanas'ev, B.V. 2003: Effectiveness of dose-intensive polychemotherapy with autologous hemopoietic cell transplantation for high-grade non-Hodgkin lymphoma Voprosy Onkologii 49(1): 66-70
Durant, J.R.; Gams, R.A.; Bartolucci, A.A.; Dorfman, R.F. 1977: BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma Cancer Treatment Reports 61(6): 1085-1096
Goss, P.E.; Burkes, R.; Rudinskas, L.; King, M.; Chow, W.; Myers, R.; Davidson, M.; Poldre, P.; Crump, M.; Sutton, D. 1994: Prednisone, oral etoposide, and novantrone for treatment of non-Hodgkin's lymphoma: a preliminary report Seminars in Hematology 31(2 Suppl. 3): 23-29
Henry-Amar, M.; Somers, R. 1990: Survival outcome after Hodgkin's disease: a report from the international data base on Hodgkin's disease Seminars in Oncology 17(6): 758-768
Balázs, L. 1990: Immunohistology of Hodgkin's disease. use of monoclonal antibodies in the analysis of the pathomorphology of Hodgkin's disease Morphologiai Es Igazsagugyi Orvosi Szemle 30(3): 182-190
Aeberhard, P.; Schröder, R.; Joss, J. 1981: Staging laparotomy in Hodgkin's disease and non-Hodgkin lymphomas: indication, technic and results Therapeutische Umschau. Revue Therapeutique 38(9): 875-880
Montalban, C.; Bellas, C.; Rodriguez-Garcia, J.L.; Aguado, M.; Fernandez-Muñoz, R. 1991: Non-Hodgkin's lymphoma after prolonged remission of Hodgkin's disease in an HIV-infected patient Annals of Oncology: Official Journal of the European Society for Medical Oncology 2(8): 585-587
Rysenga, E.; Linden, M.D.; Carey, J.L.; Ross, C.W.; Schnitzer, B.; Sawdyk, M.; Maeda, K. 1995: Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease Archives of Pathology and Laboratory Medicine 119(1): 88-91
István, L.; Balázs, L.; Brittig, F.; Pócza, K.; Szentcsiki, M.; Brenner, F. 1985: Incidence of highly malignant immunoblastic non-Hodgkin lymphoma in patients with Hodgkin's disease in remission Orvosi Hetilap 126(21): 1267-1272
Bucerius, J.; Herkel, C.; Joe, A.Y.; Altehoefer, C.; Finke, J.; Moser, E.; Reinhardt, M.J. 2006: (18)F-FDG PET and conventional imaging for assessment of Hodgkin's disease and non Hodgkin's lymphoma. An analysis of 193 patient studies Nuklearmedizin. Nuclear medicine 45(3): 105-10; quiz N25-6
Hellman, S.; Hodgkin, H.S. 1991: Thomas Hodgkin and Hodgkin's disease. Two paradigms appropriate to medicine today JAMA 265(8): 1007-1010